Screening and early detection in transfusion: when are they indicated?

被引:10
作者
Salmi, LR
Mathoulin, S
Perez, P
LawsonAyayi, S
机构
[1] Département d'Informatique Médicale, Université Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex
关键词
bacterial contamination; epidemiology; HIV; screening; transfusion; viral hepatitis;
D O I
10.1016/S1246-7820(97)80046-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Screening is proposed to allow an early intervention concerning a diseased individual, but its public health consequences are seldom considered. We propose criteria to judge whether a screening program can be associated to a benefit to patients or society. These criteria refer to the magnitude of disease, the characteristics of the pre-clinical stage, the availability of reliable and valid tests, the effectiveness and risk for all individuals, whether they are diseased or not, and acceptability to the health-care system and to individuals. We illustrate the application of these criteria to screening of human immunodeficiency virus among blood donors, hepatitis among recipients of labile blood products, and bacterial contaminations among febrile recipients. These criteria should be considered in decision analyses including alternatives to screening and all aspects of safety regarding patients and population.
引用
收藏
页码:417 / 427
页数:11
相关论文
共 48 条
[1]   TO C OR NOT TO C - THESE ARE THE QUESTIONS [J].
ALTER, HJ .
BLOOD, 1995, 85 (07) :1681-1695
[2]  
[Anonymous], ASS MED TECHN
[3]  
[Anonymous], 1994, Meta-analysis, decision analysis and cost-effectiveness analysis
[4]  
[Anonymous], 1972, PUBLIC HEALTH, DOI [DOI 10.1016/S0033-3506(02)00027-6, DOI 10.1016/S0033-3506(73)80082-4]
[5]   The role of decision analysis in transfusion medicine [J].
AuBuchon, JP .
VOX SANGUINIS, 1996, 71 (01) :1-5
[6]   POSTTRANSFUSIONAL ANTI-HCV-NEGATIVE, NON-A-HEPATITIS, NON-B-HEPATITIS .1. A PROSPECTIVE CLINICAL AND EPIDEMIOLOGIC SURVEY [J].
AZAR, N ;
VALLA, D ;
LUNEL, F ;
FRETZ, C ;
MALLET, A ;
JAULMES, D ;
FOURNEL, JJ ;
BLANC, C ;
PERRIN, M ;
AMIEL, C ;
VIARS, P ;
HABIBI, B ;
DELAGNEAU, JF ;
HURAUX, JM ;
OPOLON, P .
JOURNAL OF HEPATOLOGY, 1993, 18 (01) :24-33
[7]   POSTTRANSFUSION HEPATITIS - IMPACT OF NON-A, NON-B-HEPATITIS SURROGATE TESTS [J].
BLAJCHMAN, MA ;
BULL, SB ;
FEINMAN, SV .
LANCET, 1995, 345 (8941) :21-25
[8]   Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion [J].
Busch, MP ;
Operskalski, EA ;
Mosley, JW ;
Lee, TH ;
Henrard, D ;
Herman, S ;
Sachs, DH ;
Harris, M ;
Huang, W ;
Stram, DO .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (01) :26-33
[9]   WILL HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN SCREENING INCREASE THE SAFETY OF THE BLOOD-SUPPLY AND, IF SO, AT WHAT COST [J].
BUSCH, MP ;
ALTER, HJ .
TRANSFUSION, 1995, 35 (07) :536-539
[10]   ASSESSING THE EFFECTIVENESS OF COMMUNITY SCREENING PROGRAMS [J].
CADMAN, D ;
CHAMBERS, L ;
FELDMAN, W ;
SACKETT, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (12) :1580-1585